99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW

The most recent episodes of BrainStorm can be found below.
Thank you Genentech, Eisai, and Lundbeck for your support of BrainStorm.

53

Mary Lou Falcone - Breaking through the Silence and Stigma of Lewy Body Dementia (part 2)

Lewy Body Dementia, the second most progressive form of dementia impacting one million people in the US, is often confused with Alzheimer’s disease. In part

LISTEN NOW
52

Mary Lou Falcone - Breaking through the Silence and Stigma of Lewy Body Dementia

Lewy Body Dementia is the second most progressive form of dementia after Alzheimer's and impacts an estimated one million individuals in the United States. Symptoms

LISTEN NOW
51

Leigh Callahan, PhD – Breaking through the Silence and Stigma of Alzheimer’s (part 2)

In this episode of BrainStorm host Meryl Comer continues her care partner conversation with Leigh Callahan, a respected epidemiologist and researcher about her journey with

LISTEN NOW
50

Leigh Callahan, PhD - Breaking through the Silence and Stigma of Alzheimer’s (part 1)

The care partner is the keeper of the secrets and their perspective is essential to break through the silence and stigma of Alzheimer’s disease. In

LISTEN NOW
49

Dr. Jeremy Nobel - Loneliness and Alzheimer's

Chronic loneliness affects young and old and has been cited by the 21st US Surgeon General, Vice Admiral Vivek H. Murthy, MD as a major

LISTEN NOW